Event

David Bernard. Rubin

MD
GSK

Mona Bafadhel

Doctoral
University of Oxford

Steven W. Yancey

MBA, MS
GlaxoSmithKline;GSK

Pierluigi Paggiaro

Prof.
Respiratory Pathophysiology Unit;Università di Pisa;University of Pisa

Ian Pavord

MD, DM
Nuffield Department of Medicine and Oxford NIHR BRC, University of Oxford;Oxford University Hospitals NHS Foundation Trust;University of Oxford

Kenneth Chapman

MD
Asthma & Airway Centre, UHN and University of Toronto;University Health Network, University of Toronto;University of Toronto

Eric Speir. Bradford

MD
GlaxoSmithKline;GSK

Bhabita Mayer

MSc
GSK

Stephanie Schweiker. Harris

BSc
GSK

Frank C. Sciurba

MD
Univ of Pittsburgh Med Ctr;University of Pittsburgh;University of Pittsburgh Medical Center

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints